EUVIMEDEUVIMED entdecken
Crossref

Predictors of Overall Mortality in Pituitary Adenomas

Iustin D Toma, Dan A Niculescu iD, Raluca A Trifănescu, Simona A Găloiu, Cătălina Poiană

Experimental and Clinical Endocrinology & Diabetes · 12.10.2026

DOI: 10.1055/a-2970-2015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, online erschienen am 12.10.2026. Verfasst von Iustin D Toma und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Medicine and Pharmacy Carol Davila Bucharest, Department of Endocrinology, Bucharest, Romania, Bucharest. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various predictors of overall mortality like hypopituitarism and treatment have been demonstrated in pituitary adenomas. Whether these predictors are specific to tumor subtype was not studied. We aimed to directly compare predictors of mortality in clinically significant pituitary adenoma subtypes (acromegaly, Cushing’s disease, macroprolactinomas and non-functioning pituitary macroadenomas). We retrospectively analyzed all patients with acromegaly (n=224), Cushing’s disease (n=42), macroprolactinoma (n=123) and non-functioning pituitary macroadenomas (n=310) admitted in our department between 2011 and 2025. The following variables were retrieved: sex, age and maximum tumor diameter at diagnosis, hypopituitarism and radiotherapy. Age and tumor size at diagnosis and rates of hypopituitarism and radiotherapy varied considerably between 38 and 57 years (macroprolactinomas vs. non-functioning pituitary macroadenomas), 7 and 25 mm (Cushing’s disease vs. macroprolactinomas), 25 and 47% (acromegaly vs. non-functioning pituitary macroadenomas) and 6 and 38% (macroprolactinomas vs Cushing’s disease), respectively. Univariate analysis showed that age at diagnosis was positively associated with mortality in all pituitary adenoma subtypes while hypopituitarism was both negatively (hazard ratio=0.37, acromegaly) and positively (hazard ratio=2.71, non-functioning pituitary macroadenomas) correlated with mortality. In multivariate analysis, age at diagnosis remained a consistent predictor (hazard ratio between 1.07 and 1.11) of overall mortality across the entire cohort. Cushing’s disease was significantly associated with mortality while hypopituitarism predicted mortality only in non-functioning pituitary macroadenomas (hazard ratio=2.71). Sex, tumor size at diagnosis and radiotherapy were not associated with mortality. We confirmed that age is the main predictor of mortality in pituitary adenomas with a similar hazard ratio across all subtypes. Hypopituitarism was associated with an increased mortality only in those with non-functioning macroadenomas.

Autor:innen und Institutionen

  • University of Medicine and Pharmacy Carol Davila Bucharest, Department of Endocrinology, Bucharest, Romania, Bucharest.
  • National Institute of Endocrinology C. I. Parhon, First Endocrinology Department, Bucharest, Romania, Bucharest.

ORCID-Profile: Dan A Niculescu

Zitieren

APA

Toma, I. D., Niculescu, D. A., Trifănescu, R. A., Găloiu, S. A., & Poiană, C. (2026). Predictors of Overall Mortality in Pituitary Adenomas. Experimental and Clinical Endocrinology & Diabetes. https://doi.org/10.1055/a-2970-2015

Vancouver

Toma ID, Niculescu DA, Trifănescu RA, Găloiu SA, Poiană C. Predictors of Overall Mortality in Pituitary Adenomas. Experimental and Clinical Endocrinology & Diabetes. 2026. doi:10.1055/a-2970-2015

BibTeX
@article{Toma2026,
  author = {Toma, Iustin D and Niculescu, Dan A and Trifănescu, Raluca A and Găloiu, Simona A and Poiană, Cătălina},
  title = {Predictors of Overall Mortality in Pituitary Adenomas},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2026},
  doi = {10.1055/a-2970-2015}
}
Kostenlos starten →